Sight Sciences, Inc. (SGHT)
8.43
+0.01
(+0.12%)
USD |
NASDAQ |
Sep 03, 13:24
Sight Sciences Total Assets (Quarterly) : 104.87M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 104.87M |
| March 31, 2026 | 109.70M |
| December 31, 2025 | 115.30M |
| September 30, 2025 | 116.26M |
| June 30, 2025 | 121.97M |
| March 31, 2025 | 129.68M |
| December 31, 2024 | 142.84M |
| September 30, 2024 | 143.60M |
| June 30, 2024 | 149.72M |
| March 31, 2024 | 155.56M |
| December 31, 2023 | 166.65M |
| September 30, 2023 | 176.64M |
| Date | Value |
|---|---|
| June 30, 2023 | 185.29M |
| March 31, 2023 | 196.64M |
| December 31, 2022 | 213.07M |
| September 30, 2022 | 225.23M |
| June 30, 2022 | 240.75M |
| March 31, 2022 | 258.59M |
| December 31, 2021 | 280.19M |
| September 30, 2021 | 291.05M |
| June 30, 2021 | 52.51M |
| March 31, 2021 | 60.53M |
| December 31, 2020 | 72.81M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 3.563B |
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
| Alphatec Holdings, Inc. | 791.03M |
| AtriCure, Inc. | 676.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.98M |
| Shareholders Equity (Quarterly) | 52.89M |
| Debt to Equity Ratio | 0.7935 |
| Current Ratio | 4.948 |
| Net Debt Paydown Yield | -0.10% |